Abbott - Sponsor of the Best Large Business Award

VASCULAR CARE: CLONMEL

A healthy cardiovascular system is essential to good health. That’s why at Abbott, we’re advancing the treatment of heart and vascular disease through breakthrough medical technologies that are less invasive, allowing people to restore their health and get on with their lives.
Abbott focuses on improving treatment options for people with coronary artery disease, mitral regurgitation and peripheral artery disease. We’re working on timely advances and innovative technologies that have the potential to improve the way doctors treat people with vascular diseases.
HISTORY
Abbott’s vascular manufacturing facility in Clonmel helps meet worldwide demand for vascular devices.
The original 150,000-square-foot facility was established on 55 acres by Digital Corp in 1980. Today, the modern 250,000-square-foot facility on a 19-acre site is a centre of excellence in the manufacturing of vascular devices.
PRODUCTS MANUFACTURED
Abbott’s vascular business in Clonmel manufactures a broad range of vascular devices, including stent delivery systems.

Key products include:

• XIENCE Alpine & XIENCE Xpedition – drug-eluting stent delivery systems
• ProGlide, StarClose and Prostar , – products to facilitate secure closure of vascular access sites
• Armada 14 & Armada 18–peripheral dilatation catheters
• Omnilink Elite – a peripheral stent delivery system
• Graftmaster – a coronary stent graft system

​Abbott Vascular, Clonmel
Cashel Road
Clonmel
Tipperary
Ireland
Tel: +353 (0)52 617 3000
www.ie.abbott/about-us/abbott-in-ireland/vascular-clonmel.html
​​